Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_assertion type Assertion NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_head.
- NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_assertion description "[To better understand factors regulating TPO levels, we measured blood levels of TPO in patients with impaired platelet production due to aplastic anemia (AA) and with platelet destructive disorders, including idiopathic thrombocytopenic purpura (ITP), posttransfusion purpura (PTP), drug purpura (DP), and X-linked thrombocytopenia (XLTP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_provenance.
- NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_assertion evidence source_evidence_literature NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_provenance.
- NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_assertion SIO_000772 8639762 NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_provenance.
- NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_assertion wasDerivedFrom befree-2016 NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_provenance.
- NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_assertion wasGeneratedBy ECO_0000203 NP1350267.RA_2daGwGpGkXP1niJhzYnBtbG5JYtrtyvdlKgp5HaBV8130_provenance.